Literature DB >> 8805784

Preparation and biological activity of N-sulfonated chondroitin and dermatan sulfate derivatives.

V D Nadkarni1, T Toida, C L Van Gorp, R L Schubert, J M Weiler, K P Hansen, E E Caldwell, R J Linhardt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8805784     DOI: 10.1016/0008-6215(96)00129-2

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


× No keyword cloud information.
  5 in total

1.  Effect of 6-O-sulfonate hexosamine residue on anticoagulant activity of fully O-sulfonated glycosaminoglycans.

Authors:  T Toida; A Suzuki; K Nakajima; A Chaidedgumjorn; T Imanari
Journal:  Glycoconj J       Date:  2000-06       Impact factor: 2.916

2.  Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site.

Authors:  Z Shriver; R Raman; G Venkataraman; K Drummond; J Turnbull; T Toida; R Linhardt; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

3.  Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry.

Authors:  Guoyun Li; Chao Cai; Lingyun Li; Li Fu; Yuqing Chang; Fuming Zhang; Toshihiko Toida; Changhu Xue; Robert J Linhardt
Journal:  Anal Chem       Date:  2013-12-23       Impact factor: 6.986

4.  Solution structures of chemoenzymatically synthesized heparin and its precursors.

Authors:  Zhenqing Zhang; Scott A McCallum; Jin Xie; Lidia Nieto; Francisco Corzana; Jesús Jiménez-Barbero; Miao Chen; Jian Liu; Robert J Linhardt
Journal:  J Am Chem Soc       Date:  2008-09-04       Impact factor: 15.419

5.  Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.

Authors:  Boyangzi Li; Jiraporn Suwan; Jeffrey G Martin; Fuming Zhang; Zhenqing Zhang; Debra Hoppensteadt; Melanie Clark; Jawed Fareed; Robert J Linhardt
Journal:  Biochem Pharmacol       Date:  2009-04-21       Impact factor: 5.858

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.